Monte Carlo calculation showed that out-of-field dose was dominated by scattered radiation caused by the linac head, and the internal body scattering was not significant. This tendency was confirmed for not only ovary which is distant from the treated breast but also much nearer contralateral breast. Using RAND phantom, measured dose using the glass rod dosimeter agreed with Monte Carlo calculation within an estimated calculation precision.
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Purpose/Objective: To improve the estimates of organ doses from nuclear medicine procedures using iodine 131 (I-131) . To this end, we calculated a comprehensive set of S values, defined as organ absorbed doses per unit of nuclear transition in source regions (mGy/(Bq.s)), for I-131 using the latest reference models of the human body, which have been developed by the International Commission on Radiological Protection (ICRP). We compared our results with the S values from the Oak Ridge National Laboratory (ORNL) stylized phantoms, which are currently used in clinical dosimetry.
Materials and Methods:
We calculated the I-131 S values for the ICRP reference male and female voxel phantoms (ICRP Publication 110), using the I-131 photon and electron spectra from ICRP Publication 107 and a Monte Carlo radiation transport code, MCNPX2.6. For each phantom, we automatically defined a uniform distribution of I-131 in each of the 53 source regions. We directly computed the S values for 42 target organs without the calculation of Specific Absorbed Fraction (SAF). We obtained the S values from the ORNL stylized phantoms from earlier publications for comparison.
Results:
We calculated a comprehensive set of S values for I-131 distributed within 53 source regions of the ICRP female and male phantoms and 42 target organs and tissues. We calculated, for the first time, S values for some source and target organs (e.g., salivary gland) that were not available in the stylized phantoms but are of interest in internal dosimetry of I-131. The estimated S values from the ICRP female phantom were 1.4 times on average greater than the values from the male phantom. The S values for ICRP voxel phantoms were 1.4 and 1.9 times greater than the values from ORNL phantoms for female and male, respectively. In particular, the ICRP female values for stomach contents to the target of breasts, heart wall and adrenals were about 2 to 3 times greater than the values for ORNL.
Conclusions:
We updated the existing I-131 S values using the ICRP reference adult voxel phantoms featuring more realistic anatomy compared with the stylized phantoms. Our set of S values even enables to assess mean dose to some organs and tissues for which S values were not previously available. Our S values can be applied prospectively or retrospectively to calculate radiation doses to anyone exposed internally to I-131, including nuclear medicine patients treated for thyroid cancer or hyperthyroidism. Purpose/Objective: To compare Acuros XB and Anisotropic Analytic Algorithm (AAA) dose calculation algorithms with the Collapsed Cone Convolution (CCC) calculations derived from fluence measurements as available in COMPASS (IBA Dosimetry) for volumetric modulated arc therapy (VMAT). Materials and Methods: Five clinical cases were planned with VMAT for each of the followings: Brain, Head and Neck, Thorax, Pelvis and stereotactical body treatment, SBRT. All fluences acquired with the iMatrixx-2D detector on a Clinac-iX (Varian, Palo Alto, USA), 6MV, were the input for COMPASS system to calculate the dose distribution with CCC inside the patient. Such dose distributions were then compared with Acuros XB and AAA calculation from Eclipse treatment planning system. Comparison evaluation was based on 3-D gamma index with distance-to-agreement and dose difference criteria set to: 3mm/3% and 2mm/2% for targets, organs at risks (OAR), 50 and 10% isodose volumes. DVH of OAR and PTV from plan differences were also computed and analysed. Results: Study presented good agreement between Acuros XB or AAA and CCC. From the 3-D gamma analysis, the percentage of points passing the gamma criteria of 3mm/3% for target are shown in the 
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